title: Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation.
abstract: Chronic obstructive pulmonary disease (COPD) is frequently under-recognized and underdiagnosed. To determine the natural history of recognized and unrecognized COPD, we studied the rate of diagnosis, health care utilization, and mortality in patients with airflow limitation (AFL). Three hundred forty-seven outpatients at the Cincinnati Veterans Administration Medical Center performed spirometry and completed a respiratory questionnaire. Patients were followed for a minimum of 30 months and medical records were reviewed for COPD diagnosis, mortality, respiratory-related health care utilization, comorbidities, and respiratory medications. Three hundred twenty-five of 347 (94%) patients performed technically adequate spirometry and completed questionnaires. When AFL was defined by fixed ratio (FR, forced expiratory volume in 1 second [FEV(1)]/forced vital capacity [FVC] < 0.7), patients with AFL and a diagnosis of COPD had a higher annual mortality rate (7.1% ± 2% versus 2.4% ± 0.8%, P = 0.01), more hospitalizations per year (0.2 ± 0.06 versus 0.04 ± 0.01, P < 0.001 mean ± standard error of the mean), increased respiratory symptoms (12.0 ± 0.9 versus 7.2 ± 0.6, P < 0.0001), and higher Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage compared with undiagnosed patients. Ninety-two of 137 patients with AFL (67%) had unrecognized AFL; 16 (17%) of the 92 were subsequently diagnosed. When AFL was defined by the lower limit of normal (LLN, FEV(1)/FVC < LLN), 67 of 103 patients (65%) had unrecognized AFL; 12 (18%) of the 67 were subsequently diagnosed. Patients with AFL defined by FR who were subsequently diagnosed had more emergency department visits per year (0.33 ± 0.11 versus 0.11 ± 0.05, P = 0.009), increased respiratory symptoms (10.2 ± 1.6 versus 6.5 ± 0.7, P < 0.05), and higher GOLD stage, but similar mortality and hospitalizations compared with the persistently undiagnosed patients. The annual rate of documented COPD diagnosis was 7% for both FR and LLN definitions. Patients with AFL and a diagnosis of COPD have more severe disease, higher health care utilization, and mortality than undiagnosed patients. The annual rate of COPD diagnosis is 7% among individuals with unrecognized AFL. Worse AFL, increased respiratory symptoms, and ED visits are associated with a subsequent COPD diagnosis in individuals with unrecognized AFL.
authors: Pulmonary, Critical Care and Sleep Medicine Division, Cincinnati Veterans Affairs Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
authors: Daniel E
authors: DE
authors: Murphy
authors: Ralph J
authors: RJ
authors: Panos
mesh_terms: D000328:Adult; D015897:Comorbidity; D003951:Diagnostic Errors / Q000517:prevention & control*; D061345:Early Medical Intervention; D005260:Female; D006296:Health Services / Q000706:statistics & numerical data; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology; D012129:Respiratory Function Tests / Q000706:statistics & numerical data; D012307:Risk Factors; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D016019:Survival Analysis; D014481:United States / Q000453:epidemiology; D058014:Veterans Health / Q000706:statistics & numerical data
keywords: COPD; Veterans Healthcare Administration; airflow limitation; diagnosis
references: Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
references: 11316667
references: Arch Intern Med. 2000 Jun 12;160(11):1683-9
references: 10847262
references: Am J Respir Crit Care Med. 2011 Nov 1;184(9):1015-21
references: 21836135
references: Value Health. 2008 Jul-Aug;11(4):628-36
references: 18194402
references: Natl Vital Stat Rep. 2011 Mar;59(4):1-51
references: 25073815
references: Respir Res. 2007 Jul 02;8:45
references: 17605774
references: Natl Vital Stat Rep. 1999 Jun 30;47(19):1-104
references: 10410536
references: Am J Respir Crit Care Med. 1999 Jan;159(1):179-87
references: 9872837
references: Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36
references: 7663792
references: Prim Care Respir J. 2011 Mar;20(1):15-22
references: 20871945
references: COPD. 2005 Jun;2(2):277-83
references: 17136954
references: Respir Res. 2005 Aug 25;6:98
references: 16120227
references: COPD. 2005 Dec;2(4):427-34
references: 17147008
references: Mil Med. 2011 May;176(5):552-60
references: 21634301
references: Prim Care Respir J. 2009 Sep;18(3):198-207
references: 19492178
references: Am J Respir Crit Care Med. 2012 Jun 15;185(12):1301-6
references: 22561963
references: Chest. 2010 Sep;138(3):605-13
references: 20418365
references: Chest. 2012 Jan;141(1):73-80
references: 21659434
references: Respir Care. 2006 Oct;51(10):1120-4
references: 17005056
references: Prim Care Respir J. 2011 Dec;20(4):396-402
references: 21687918
references: Eur Respir J. 1991 Mar;4(3):257-66
references: 1864340
references: Chest. 2011 May;139(5):1072-1080
references: 21183609
references: Am J Respir Crit Care Med. 2009 Mar 1;179(5):369-74
references: 19074596
references: COPD. 2008 Apr;5(2):85-95
references: 18415807
references: Thorax. 2000 Feb;55(2):114-20
references: 10639527
references: Respirology. 2003 Dec;8(4):504-8
references: 14629656
references: Respir Med. 2008 Dec;102(12):1744-52
references: 18760581
references: Chest. 2009 Apr;135(4):975-982
references: 19017866
references: Am J Respir Crit Care Med. 2009 Sep 1;180(5):407-14
references: 19542480
references: Int J Tuberc Lung Dis. 2008 Jul;12(7):709-12
references: 18544192
references: PLoS Med. 2006 Nov;3(11):e442
references: 17132052
references: Respirology. 2004 Nov;9(4):458-65
references: 15612956
references: Soz Praventivmed. 2005;50(4):245-63
references: 16167509
references: Respiration. 2011;81(6):476-82
references: 20720402
references: Respir Res. 2009 Jun 30;10:59
references: 19566934
references: Lancet. 1997 May 24;349(9064):1498-504
references: 9167458
references: Am J Respir Crit Care Med. 2009 Nov 15;180(10):956-63
references: 19696441
references: Thorax. 2000 Sep;55(9):746-50
references: 10950892
references: Eur Respir J. 2002 Oct;20(4):799-805
references: 12412667
references: Lancet. 2009 Oct 3;374(9696):1171-8
references: 19716598
references: COPD. 2005 Jun;2(2):225-32
references: 17136949
references: Thorax. 2000 Sep;55(9):729-30
references: 10950888